Pancreatic Cancer Research

ResearcherThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteActive in the last 2 years

Carlo M Croce

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3788-1457; OpenAlex author ID A5079700663; NIH RePORTER profile ID 1868202. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 1)
Trials
0
Grants
1
Labs led
1
Collaborators
15
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 grant · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 6

  1. Fra-2 controls the response to the KRAS inhibitor MRTX-1133 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1073/pnas.2601788123↗
  2. Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41392-024-01740-4↗
  3. Will detection of microRNA biomarkers in blood improve the diagnosis and survival of patients with pancreatic cancer? First author DOI 10.1001/jama.2013.284665↗
  4. A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma. Co-author DOI 10.1245/s10434-013-3240-y↗
  5. Hypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells. Co-author DOI 10.1016/j.jss.2013.04.061↗
  6. MicroRNA-375 and MicroRNA-221: Potential Noncoding RNAs Associated with Antiproliferative Activity of Benzyl Isothiocyanate in Pancreatic Cancer. Co-author DOI 10.1177/1947601911409212↗

Grants 1

  1. Cancer Gene Discovery to Identify Targetable Targets R35CA197706↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gian Luca Rampioni Vinciguerra · 2 shared papers, 2024–2026 · strength 0.40
  2. Erika Testa · 1 shared paper, 2026 · strength 0.23
  3. Vincenzo Corbo · 1 shared paper, 2026 · strength 0.23
  4. Geny Piro · 1 shared paper, 2026 · strength 0.23
  5. Carmine Carbone · 1 shared paper, 2026 · strength 0.23
  6. Donald J Buchsbaum · 1 shared paper, 2014 · strength 0.09
  7. Mark Bloomston · 2 shared papers, 2013–2014 · strength 0.09
  8. Amy Collins · 2 shared papers, 2013–2014 · strength 0.09
  9. Thomas A. Mace · 1 shared paper, 2013 · strength 0.04
  10. Gregory B. Lesinski · 1 shared paper, 2013 · strength 0.04
  11. Lianbo Yu · 1 shared paper, 2014 · strength 0.04
  12. Wendy L. Frankel · 1 shared paper, 2014 · strength 0.04
  13. Thomas D. Schmittgen · 1 shared paper, 2014 · strength 0.04
  14. A. Basu · 1 shared paper, 2011 · strength 0.03
  15. Subrata Haldar · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.